Skip to content

Text Messaging Adherence to Stimulant Medication

Text Messaging Adherence to Stimulant Medication

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01967485
Enrollment
35
Registered
2013-10-23
Start date
2014-01-31
Completion date
2016-09-30
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Keywords

Attention Deficit Hyperactivity Disorder, Medication adherence, Disease management, Text message, ADHD, Children, Reminder systems, Text Messaging, Telemedicine

Brief summary

The purpose of this study is to determine if an individualized text messaging intervention for the parents of children with Attention Deficit/Hyperactivity Disorder is effective in improving medication adherence and disease management.

Interventions

OTHERText- Messaging

Text messages will be sent to the parents of children enrolled in the study.

OTHERTreatment as usual

Children will receive stimulant treatment for ADHD.

Sponsors

American Academy of Child Adolescent Psychiatry.
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Male or female children ages 6-17 years * A diagnosis of ADHD (inattentive, hyperactive/impulsive, or combined type) according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) based on clinical assessment and supported by a Clinical Global Impression- ADHD (CGI-ADHD) Severity Score of at least 4 (Moderately Ill) * Has a parent in possession of a cellular phone with text messaging capabilities and is interested in and willing to receive planned text messages * Has never been treated with stimulant medication, or has begun treatment with stimulant medication within three months of study enrollment.

Exclusion criteria

* Any serious, unstable, chronic medical condition, per clinician assessment * Cardiovascular disease * Current or past history of seizures * Treatment with stimulant medication beyond three months prior to enrollment * Pregnant or nursing females * Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent, or grandchild * Unstable psychiatric illness other than ADHD, including, but not limited to: Autism, Bipolar Disorder, Psychosis, Major Depressive Disorder, Anorexia, Bulimia, Post-Traumatic Stress Disorder and Anxiety Disorders * History of multiple adverse drug reactions * Presence of suicidal risk, or homicidality * Unwilling/unable to comply with study procedures * Poor command of the English language

Design outcomes

Primary

MeasureTime frameDescription
Medication AdherenceSix MonthsAdherence to the individualized medication regimen

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026